Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > These are high stakes folks!!!

<< Previous

Bullboard Posts

Next >>

Comment by CMHarring218431on Dec 17, 2024 11:03am

101 Views

Post# 36366244

RE:RE:RE:RE:These are high stakes folks!!!

Frustration....MM's, shorts, tax loss selling are all weighing heavy on the stock price. No news Tuesday probably caused someone(s) to dump right before and after market open. Many longs here with mucho amount of shares might be unloading a small portion just to take advangtage of the maximum tax loss. If they get bought out, that figure won't amount to a hill of beans. Just casual thoughts

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?